Table 1.
Author | EMR/ESD | Patients | Surgery | ADC/SCC | Positive resection margin | Other therapy | Local recurrence | Meta-chronous | N (+) | L (+) | Re-classification | Grade 3 | In situ | Piecemeal resection |
Buttar et al[10] | EMR | 17 | 0 | ADC | 3 | PDT | 8 | 0 | ||||||
Chaves et al[11] | ESD | 5 | SCC | 0 | 0 | 3 | 1 | |||||||
Chennat et al[12] | EMR | 49 | 3 | ADC | 0 | 22 | 0 | |||||||
Ciocirlan et al[13] | EMR | 51 | 2 | SCC | 14 | CHEMO | 8 | 2 | 0 | 4 | 36 | |||
Conio et al[14] | EMR | 39 | 3 | ADC | 0 | 1 | 2 | 10 | 5 | 0 | ||||
Ell et al[15] | EMR | 64 | 5 | ADC | PDT/APC | 6 | 3 | 6 | 6 | 0 | ||||
Espinel et al[16] | EMR | 4 | 1 | ADC | 1 | 0 | 0 | |||||||
Fujishiro et al[17] | ESD | 43 | SCC | 7 | 1 | 1 | 1 | 24 | 0 | |||||
Gerke et al[18] | EMR | 41 | ADC | 9 | RFA | 3 | 0 | 0 | ||||||
Goda et al[19] | EMR | 58 | 1 | SCC | CRT | 1 | 0 | |||||||
Higuchi et al[20] | EMR | 20 | 0 | SCC | 6 | CRT/APC | 0 | 0 | 0 | 6 | 1 | 0 | ||
Hull et al[52] | EMR | 10 | ADC | 2 | 0 | |||||||||
Iguchi et al[21] | EMR | 8 | 1 | SCC | 0 | 4 | ||||||||
Ishihara et al[22] | EMR/ESD | 70 | SCC | CRT | 12 | 0 | 40 | |||||||
Ishii et al[23] | ESD | 35 | 1 | SCC | 2 | CHEMO | 0 | 1 | 28 | 0 | ||||
Larghi et al[24] | EMR | 40 | 5 | ADC | PDT/APC | 0 | 6 | 19 | ||||||
Lewis et al[25] | EMR | 100 | 1 | ADC | 1 | PDT | 1 | 8 | ||||||
Lin et al[26] | EMR | 9 | 1 | SCC | 0 | 1 | 0 | 0 | 1 | 0 | 7 | |||
Lopes et al[27] | EMR | 41 | 1 | ADC | APC/CRT | 4 | 2 | 14 | 2 | |||||
Maish et al[28] | EMR | 7 | 7 | ADC | 1 | 0 | 4 | 0 | ||||||
Manner et al[6] | EMR/ESD | 21 | 1 | ADC | 27 | APC | 3 | 2 | 0 | 0 | 0 | |||
Naritaka et al[29] | EMR | 13 | 1 | SCC | 2 | RT | 1 | 7 | 9 | |||||
Nijhawan et al[30] | EMR | 25 | 2 | ADC | PDT | 0 | 11 | |||||||
Noguchi et al[31] | EMR | 33 | 5 | SCC | CRT | 0 | 5 | 14 | 15 | |||||
Nomura et al[32] | EMR | 51 | 1 | SCC | CRT | 4 | 30 | 41 | ||||||
Nonaka et al[33] | ESD | 25 | 1 | SCC | 3 | RT/CRT | 0 | 10 | 0 | 0 | ||||
Ohashi et al[90] | EMR | 179 | SCC | 13 | 68 | |||||||||
Ono et al[34] | ESD | 84 | 9 | SCC | 7 | CRT | 1 | 2 | 2 | 0 | 0 | |||
Ota et al[35] | EMR | 18 | 0 | SCC | 5 | CRT | 0 | 4 | 11 | 3 | 0 | |||
Pech et al[3] | EMR/ESD | 39 | SCC | 20 | PDT/CHEMO | 5 | 2 | 7 | 1 | 10 | ||||
Peters et al[53] | EMR/ESD | 141 | ADC | 37 | 1 | 73 | 14 | |||||||
Pouw et al[37] | EMR/ESD | 34 | 1 | ADC | APC | 3 | 14 | 10 | ||||||
Prasad et al[39] | EMR | 25 | 25 | ADC | 17 | 5 | 16 | |||||||
Repici et al[51] | ESD | 20 | 2 | SCC | 1 | 0 | 0 | 1 | 2 | 3 | 0 | |||
Scheil-Bertram et al[40] | EMR | 16 | 16 | ADC | 16 | 1 | ||||||||
Schröder et al[41] | EMR | 16 | ADC/SCC | 9 | 3 | 13 | 1 | |||||||
Shimizu et al[42] | EMR | 82 | SCC | APC | 2 | 12 | 16 | |||||||
Takeo et al[44] | EMR | 29 | 5 | 0 | 0 | 15 | 10 | |||||||
Tanabe et al[46] | EMR | 85 | 0 | SCC | 15 | APC/CRT | 5 | 0 | 41 | |||||
Teoh et al[47] | EMR/ESD | 28 | SCC | 6 | RT/CRT | 1 | 1 | |||||||
Urabe et al[48] | EMR/ESD | 122 | SCC | 6 | 56 | |||||||||
Vieth et al[54] | EMR | 295 | ADC | 210 | 10 | 22 | ||||||||
Yokoyama et al[49] | EMR | 17 | 0 | SCC | RT | 7 | ||||||||
Zehetner et al[50] | EMR | 28 | 3 | ADC | 0 | RFA | 5 | 3 | 2 | 2 |
EMR: Endoscopic mucosal resection; ESD: Endoscopic submucosal dissection; SCC: Squamous carcinoma; ADC: Adenocarcinoma; APC: Argon plasma coagulation; PDT: Photodynamic therapy; CRT: Chemoradiation therapy; RFA: Radiofrequency ablation; RT: Radiology; CHEMO: Chemotherapy.